Clinical trial
Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV…
NCT00262106 · Endo Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00262106 |
|---|---|
| Title | Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection |
| Official title | An International Multi-centre, Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of 0.5% and 2% PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection |
| Lead sponsor | Endo Pharmaceuticals, Industry |
| Collaborators | Medical Research Council Department for International Development, United Kingdom |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, Gonorrhea, Chlamydial Infections, Genital Herpes |
| Intervention type | Drug |
| Interventions | PRO 2000/5, Placebo |
| Enrollment | 9,404 |
| Start date | Oct 1, 2005 |
| Primary completion | Aug 1, 2008 |
| Completion | Sep 1, 2009 |
| First posted | Dec 6, 2005 |
| Last update posted | Sep 10, 2012 |
| Countries | South Africa, Tanzania, Uganda, Zambia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: